Poly Medicure Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
Key Metrics
PE ratio
56.98
PB ratio
5.77
Dividend yield
0.20%
Beta
0.01
Market cap
₹179.28B
Enterprise value
₹176.44B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Full time employees | 2614 |
| Website | https://www.polymedicure.com |
| Mailing address | 232-B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India |
| Phone / Fax | 91 11 4731 7000 / 91 11 2632 1839 |
Dividends
Dividend yield
0.20%
Dividend amount
₹3.50
Payout ratio
11.27%
5Y Avg. yield
-%
Poly Medicure Limited paid ₹3.50 dividend and the ex-dividend date was 28 Aug 2026.The dividend payout ratio is 11.27%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.POLYMED dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Poly Medicure Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Himanshu Baid | CEO, MD & Director | 57 | |
| Mr. Jugal Kishore Baid | Founder & Non Executive Director | 83 | |
| Mr. Naresh Vijayvergiya | Chief Financial Officer | 57 | |
| Mr. Avinash Chandra | Company Secretary & Compliance Officer | ||
| Mr. Rishi Baid B.S.M.E | Joint MD & Executive Director | 53 | |
| Mr. Vishal Baid C.A. | Executive Director & Senior VP of Corporate Sales & Marketing | 51 | |
| Mr. Pankaj Kumar Gupta B.E. | President of R&D & Additional Executive Director | 58 | |
| Mr. Ravi Prakash | Deputy Company Secretary | ||
| Mr. P. K. Rastogi C.A. | Assistant Vice President of Finance & Accounts | 54 | |
| Mr. Rahul Gautam | President of Strategy & Corporate Development |
Profitability and management effectiveness
Profit margin
15.77%
Operating margin
16.91%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Poly Medicure Limited is 179.28B and its enterprise value is 176.44B. The enterprise value to revenue ratio of POLYMED is 8.83. The enterprise value to EBITDA ratio of POLYMED is 38.61.
The POLYMED's stocks Beta value is 0.01 making it 99% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Poly Medicure Limited (NSE:POLYMED) Frequently Asked Questions
1. What is Poly Medicure Limited's Stock Symbol?
Poly Medicure Limited trades on NSE under the ticker symbol "POLYMED".
2. What is Poly Medicure Limited's stock price today?
One share of POLYMED stock can currently be purchased for approximately ₹1768.7.
3. How can I contact Poly Medicure Limited?
Poly Medicure Limited's mailing address is 232-B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India. The company can be reached via phone at 91 11 4731 7000.
4. What is Poly Medicure Limited's official website?
The official website of Poly Medicure Limited is https://www.polymedicure.com.